186 related articles for article (PubMed ID: 17336005)
1. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
Wei G; Lu LF; Lu WY
Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
3. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
Pérez C; Griebenow K
Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
[TBL] [Abstract][Full Text] [Related]
4. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
5. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
[TBL] [Abstract][Full Text] [Related]
6. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
[TBL] [Abstract][Full Text] [Related]
7. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
8. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
Cleland JL; Jones AJ
Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
[TBL] [Abstract][Full Text] [Related]
9. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
[TBL] [Abstract][Full Text] [Related]
10. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
Taluja A; Bae YH
Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
[TBL] [Abstract][Full Text] [Related]
11. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres.
Yang TH; Dong A; Meyer J; Johnson OL; Cleland JL; Carpenter JF
J Pharm Sci; 1999 Feb; 88(2):161-5. PubMed ID: 9950632
[TBL] [Abstract][Full Text] [Related]
12. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
13. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
14. The stabilization and encapsulation of human growth hormone into biodegradable microspheres.
Johnson OL; Jaworowicz W; Cleland JL; Bailey L; Charnis M; Duenas E; Wu C; Shepard D; Magil S; Last T; Jones AJ; Putney SD
Pharm Res; 1997 Jun; 14(6):730-5. PubMed ID: 9210189
[TBL] [Abstract][Full Text] [Related]
15. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism.
Kim HK; Park TG
Biotechnol Bioeng; 1999 Dec; 65(6):659-67. PubMed ID: 10550772
[TBL] [Abstract][Full Text] [Related]
16. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
18. Development of a sustained-release recombinant human growth hormone formulation.
Kwak HH; Shim WS; Choi MK; Son MK; Kim YJ; Yang HC; Kim TH; Lee GI; Kim BM; Kang SH; Shim CK
J Control Release; 2009 Jul; 137(2):160-5. PubMed ID: 19332090
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH.
Wang C; Yu C; Liu J; Teng L; Sun F; Li Y
Int J Pharm; 2015 Nov; 495(2):924-31. PubMed ID: 26456269
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
Shelke NB; Aminabhavi TM
Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
